Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Biofrontera Inc (BFRI)

Biofrontera Inc (BFRI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,495
  • Shares Outstanding, K 26,699
  • Annual Sales, $ 24,100 K
  • Annual Income, $ -37,710 K
  • 60-Month Beta 1.03
  • Price/Sales 0.72
  • Price/Cash Flow N/A
  • Price/Book 0.94
Trade BFRI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.17
  • Most Recent Earnings -0.23 on 11/14/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 520.50% ( +42.72%)
  • Historical Volatility 70.52%
  • IV Percentile 87%
  • IV Rank 48.02%
  • IV High 1,080.09% on 05/12/22
  • IV Low 3.58% on 05/18/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 0
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 212
  • Open Int (30-Day) 214

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +69.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8200 +3.66%
on 02/08/23
1.1197 -24.09%
on 01/09/23
-0.0500 (-5.56%)
since 01/06/23
3-Month
0.7501 +13.32%
on 12/21/22
1.1197 -24.09%
on 01/09/23
-0.0798 (-8.58%)
since 11/08/22
52-Week
0.7501 +13.32%
on 12/21/22
6.1200 -86.11%
on 04/13/22
-3.0700 (-78.32%)
since 02/08/22

Most Recent Stories

More News
Biofrontera Inc. (BFRI) Reports Q3 Loss, Tops Revenue Estimates

Biofrontera Inc. (BFRI) delivered earnings and revenue surprises of 28.13% and 0.05%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

BFRI : 0.8500 (-3.41%)
VBLT : 0.1590 (-1.67%)
Entera Bio Ltd. (ENTX) Reports Q3 Loss, Misses Revenue Estimates

Entera Bio Ltd. (ENTX) delivered earnings and revenue surprises of 31.25% and 88.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

ENTX : 0.9500 (+2.15%)
BFRI : 0.8500 (-3.41%)
Curis (CRIS) Reports Q3 Loss, Misses Revenue Estimates

Curis (CRIS) delivered earnings and revenue surprises of 17.65% and 6.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

CRIS : 0.7570 (-0.47%)
BFRI : 0.8500 (-3.41%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

Palm Beach, FL – October 4, 2022 – FinancialNewsMedia.com News Commentary –  The laser therapy market has been having a very health growth trend in recent years and is expected to continue through...

PIXY : 9.28 (unch)
EW : 78.08 (-2.45%)
BFRI : 0.8500 (-3.41%)
LITE : 61.17 (-0.44%)
CUTR : 34.39 (-2.83%)
Global Laser Therapy Devices Billion Dollar Market Thriving on Growing Demand

/PRNewswire/ -- The laser therapy market has been having a very health growth trend in recent years and is expected to continue through the coming years....

PIXY : 9.28 (unch)
EW : 78.08 (-2.45%)
BFRI : 0.8500 (-3.41%)
LITE : 61.17 (-0.44%)
CUTR : 34.39 (-2.83%)
Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted to Biofrontera Bioscience GmbH

Patent Improves Differentiated Profile of Ameluz-PDT by Expected Reduced Pain Intensity while Maintaining Efficacy WOBURN, Mass., Aug. 01, 2022 (GLOBE...

BFRI : 0.8500 (-3.41%)
BFRIW : 0.2900 (unch)
Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Private Placement

WOBURN, Mass., July 27, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.2900 (unch)
BFRI : 0.8500 (-3.41%)
Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing Excellence

Named Among the 10 Fastest-Growing Life Sciences Companies to Watch in 2022 by CIOCoverage Magazine New Ameluz® Marketing Campaign Receives Gold 2022...

BFRI : 0.8500 (-3.41%)
BFRIW : 0.2900 (unch)
Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference

WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.2900 (unch)
BFRI : 0.8500 (-3.41%)
New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial Opportunity for Biofrontera’s Ameluz®

WOBURN, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of...

BFRIW : 0.2900 (unch)
BFRI : 0.8500 (-3.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields of photodynamic therapy and topical antibiotics. The Company's licensed products focus on the treatment of actinic keratoses,...

See More

Key Turning Points

3rd Resistance Point 1.0032
2nd Resistance Point 0.9605
1st Resistance Point 0.9053
Last Price 0.8500
1st Support Level 0.8074
2nd Support Level 0.7647
3rd Support Level 0.7095

See More

52-Week High 6.1200
Fibonacci 61.8% 4.0687
Fibonacci 50% 3.4351
Fibonacci 38.2% 2.8014
Last Price 0.8500
52-Week Low 0.7501

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar